ALBUQUERQUE, N.M. (KRQE) – Presbyterian is now offering monoclonal antibody therapy for COVID-19 patients. The treatment is only available for those ages 12 and older who are at high risk of COVID hospitalization.
Story continues below
- Albuquerque: Over 200 stranded overnight on top of tram after storm cuts power
- New Mexico: New Mexico cannabis sales set new summer record
- Crime: Prosecutors rush to keep accused parade-crasher in jail until trial
- KRQE En Español: Lunes 8 de Agosto 2022
Treatment should be started within 10 days of symptoms and a positive COVID test. A full list of requirements to receive the treatment is available online.
